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PU.1 and GATA-3 are transcription factors that are required for development of T cell progenitors from the earliest stages.
Neither one is a simple positive regulator for T lineage specification, however. When expressed at elevated levels at early
stages of T cell development, each of these transcription factors blocks T cell development within a different, characteristic
time window, with GATA-3 overexpression initially inhibiting at an earlier stage than PU.1. These perturbations are each
associated with a distinct spectrum of changes in the regulation of genes needed for T cell development. Both transcription
factors can interfere with expression of the Rag-1 and Rag-2 recombinases, while GATA-3 notably blocks PU.1 and IL-7R
expression, and PU.1 reduces expression of HES-1 and c-Myb. A first-draft assembly of the regulatory targets of these two
factors is presented as a provisional gene network. The target genes identified here provide insight into the basis of the
effects of GATA-3 or PU.1 overexpression and into the regulatory changes that distinguish the developmental time windows
for these effects. © 2002 Elsevier Science (USA)
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Hematopoiesis is the process by which hematopoietic
stem cells give rise to at least 10 distinct mature blood cell
types. Blood cell development initiates in the embryo but
also continues throughout the lifetime of the adult animal,
thus providing a unique model system for studying the
mechanisms underlying transcriptional control of develop-
ment, as further described elsewhere (Rothenberg and
Anderson, 2002). T cell development is particularly acces-
sible for detailed study due to the segregation of T lineage
precursors into a distinct organ, the thymus. Targeted
disruption (“knockout”) experiments have identified a
number of transcription factors that are necessary for T cell
development, but none of these factors is both necessary
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All rights reserved.and sufficient to generate T cells. In fact, as described in the
companion paper (Rothenberg and Anderson, 2002), hema-
topoietic development appears to be highly dependent on
specific combinations of transcription factors that operate
within narrowly defined temporal windows. Not only are
the correct combinations needed, but also the correct doses
at the correct times. The sets of interactions that control T
lineage determination can be theoretically diagrammed as a
network in which certain combinations of input events lead
to specific output events. We are in the early stages of
probing the interactions between known transcriptional
regulators, growth factor receptors, and effector genes in
order to construct such a network for the earliest stages of
T cell development. This network will provide a framework
for further testing the relationships between regulators that
bias cells toward different fates under different conditions.
Hematopoietic precursors migrate to the thymus to un-
dergo T cell development at a stage when they are still
incompletely committed to a T cell fate. Although most0756 or (626) 584-9075. E-mail: evroth@its.caltech.edu.103
options are closed off prethymically, the cells retain the
ability to differentiate into NK cells or even the myeloid-
like dendritic cells in the initial stages of their intrathymic
residence (Res et al., 1996; Shortman et al., 1998; Ikawa et
al., 1999; Lee et al., 1999; Michie et al., 2000). Other
precursors entering the thymus, apparently separately, can
generate small numbers of intrathymic B cells (Kawamoto
et al., 1998). In general, though, the thymus appears to
block any B cell potential of the immigrants that give rise to
T cell progeny, probably via strong signals through Notch-1
(Wilson et al., 2001; Koch et al., 2001). Precursor differen-
tiation toward a T lineage committed state is marked by
clear changes in cell surface marker expression (Shortman
and Wu, 1996; Rothenberg et al., 1999; Rothenberg, 2000).
While mature T cells express either CD4 or CD8 on the cell
surface, the earliest precursors do not express either (double
negative, “DN,” i.e., CD4CD8), and they transiently
acquire both CD4 and CD8 (“DP,” double positive) before
undergoing immunological selection and maturation.
These stages are summarized for reference in Fig. 1, and
details are provided in the legend to that figure (for addi-
tional reviews of early T cell development, see Rodewald
and Fehling, 1998; Spits et al., 1998; Haks et al., 1999;
MacDonald et al., 2001). These stages and their gene
expression properties have been characterized extensively
in postnatal mice; fetal T cell development differs in some
respects but is broadly similar.
Figure 1 shows several important landmarks in T cell
development, all of which occur in cells at distinct stages of
differentiation within the DN population (DN1–DN4). The
first of these is T lineage specification at the DN2 stage.
This is marked, in mice, by the onset of CD25, Thy-1, and
HSA (CD24) expression at the cell surface, and by a broad
set of positive and negative regulatory changes establishing
the stable activity of a T cell gene battery. This is also the
stage when the immune receptor gene recombinases, Rag-1
and Rag-2, are first expressed. At the same time, the cells
become dependent on IL-7/IL-7R interaction for prolifera-
tion and for much of their survival, and they become
strongly biased toward a T lineage fate, although they can
still give rise to some natural killer (NK) cells and/or
myeloid-like dendritic cells (DC). T lineage specification
occurs as the cells make the transition to the “DN2” stage
from a DN1 Thy-1low, Sca-1 precursor subset.
FIG. 1. Summary of T cell development, subsets of precursors. Phenotypically distinct stages, developmental branch points, and check
points in T cell development. Major developmental transitions are indicated by the italicized phrases in boxes below the progression of
stages, and the range of expression of key markers used to distinguish certain developmental stages are indicated by broken lines. Thick
black arrows denote developmental progression. The earliest lymphoid precursors are contained within the “DN1” (CD44 c-kit CD25
HSAlow) population, but are found mostly or exclusively in a Thy-1low Sca-1 minority subset (M. A. Yui, R. A. Diamond, and E.V.R.,
unpublished data). Without further fractionation, the crude “DN1” population can also include NK-like cells (Sca-1low) and others. DN2
cells (Thy-1 CD44 c-kit CD25 HSA, proliferating) are the first stage that is highly biased to a T lineage fate and expresses a T
lineage-specific gene battery. DN3 cells (Thy-1 CD44 c-kit CD25 HSA, mostly resting) are T lineage-committed. Cell types at the
successive stages are characterized by common abbreviations: DN, double negative, for cells lacking CD4 and CD8 expression; DP, double
positive, for cells that express both CD4 and CD8; ISP, immature “single positive,” i.e., immature cells that express CD8 without CD4 or
high levels of surface TCR, which are intermediates between DN and DP stages; NK, natural killer cell; DC, dendritic cell; Mac,
macrophage. At the far right of the figure, the most mature T cell types are indicated by their coexpression of CD4 with high levels of
cell-surface T cell receptor (TCR) or by coexpression of CD8 with high levels of TCR. Lymphoid Precursor, putative common lymphoid
precursor or T/NK/DC precursor; L/M Pre, hypothetical common lymphoid/myeloid precursor. Note that cells after specification, in the
DN2 stage, still have some ability to differentiate to non-T fates, such as NK or DC (gray open arrow). For a more complete discussion, see
previous reviews (Rothenberg et al., 1999; Rothenberg, 2000).
104 Anderson et al.
© 2002 Elsevier Science (USA). All rights reserved.
The second landmark is T lineage commitment at the
DN3 stage. This is the transition at which precursors
relinquish the ability to give rise to anything except forms
of T cells. In adult mice, it is associated with a slowing or
arrest of cell division, and a transition from dependence on
IL-7/IL-7R signaling to a dependence on expression of a
pre-TCR complex for any further proliferation and long-
term survival. Commitment occurs in the transition from
the “DN2” to the “DN3” state. Growth arrest at this stage
allows maximal Rag recombinase activity and improves the
chance of a successful TCR chain gene rearrangement
encoding a functional protein product. Cells that have
managed to express both chains of a TCR receptor may
undergo commitment and begin final maturation as TCR
cells without passing through the DN3 state and without
acquiring CD4 or CD8 expression.
The third landmark is -selection. This is the major
developmental and physiological transition through which
cells pass when they succeed in making a productive TCR
chain gene rearrangement. The cells are rewarded by a
massive proliferative expansion and differentiation from
the “DN” compartments to express CD4 and CD8, thus
becoming “double positive” (DP) CD4 CD8 cells.
-Selection itself is interesting in that the powerful signal-
ing events at this stage precipitate a major discontinuity in
transcription factor gene expression (Anderson et al., 1999;
Kruisbeek et al., 2000; Engel et al., 2001; M.K. Anderson
and G.U. Rothman, unpublished observations). From this
point on, the cells have concluded their hematopoietic
lineage choices and are subject primarily to immunological
selection events that are beyond the scope of our studies.
Genetic evidence indicates that the transcription factors
PU.1 and GATA-3 are both important for early T cell devel-
opment (Scott et al., 1994; McKercher et al., 1996; Ting et al.,
1996). However, PU.1 expression at high levels drives precur-
sors to a myeloid (macrophage or granulocyte) cell fate and
blocks lymphoid development (DeKoter and Singh, 2000;
Anderson et al., 2002). Studies in the erythromyeloid system
have shown that GATA family factors and PU.1 can act as
mutual antagonists for expression of genes that are targets of
one but not the other (Rekhtman et al., 1999; Zhang et al.,
1999; Nerlov et al., 2000; Matsumura et al., 2000). GATA-3
expression is essential for T cell development from the earliest
recognizable stage (Ting et al., 1996; Hendriks et al., 1999),
but GATA-3 overexpression in hematopoietic precursors can
also block lymphoid development, promoting erythroid/
megakaryocytic fates (Chen and Zhang, 2001). It therefore is
possible that PU.1 and GATA-3 interact in a dose-dependent
way in early thymic precursors to specify the T cell fate. Here,
we examine the effects of GATA-3 overexpression on entry
into the T cell pathway, and link potential targets of PU.1 and
GATA-3 into a regulatory network that may help explain the
dose restrictions of both PU.1 and GATA-3 in early T cell
development.
MATERIALS AND METHODS
Thymocyte Developmental Subsets
Thymocytes were obtained from TCR// or Rag-2/ mice
for the DN1–DN3 populations, and from C57BL/6 (normal) mice or
from major histocompatibility complex (MHC)-deficient mice for
the transitional, immature CD8 single positive (ISP) and DP
populations, as previously described in detail (Anderson et al.,
1999) (see Fig. 1). TCR/ / and Rag-2/ thymocytes consist
almost exclusively of DN1–DN3 cells because they cannot undergo
-selection or generate TCR cells, greatly simplifying DN subset
purification. For the DN1 subsets, the HSA cells (i.e., DN2 and
DN3 subsets) were removed by magnetic column separation
(Miltenyi Biotec), and the remaining cells were fractionated on the
basis of Sca-1 and Thy-1 expression by flow cytometry (FACS
Vantage SE; Becton-Dickinson), using a third color to exclude
residual HSA and/or CD25 DN2 and DN3 cells. In some experi-
ments, 7-amino actinomycin D staining was also used to exclude
dead cells, and F4/80 and Gr-1 were added to the HSA antibody to
ensure exclusion of any mature myeloid cells. The DN2, DN3, ISP,
and DP populations were sorted as previously described (Anderson
et al., 1999).
Retroviral Constructs
Bicistronic LZRS-IRES-GFP retroviral constructs (Heemskerk et
al., 1997) expressing GFP and either PU.1 or GATA-3 were con-
structed and transfected into NX-Eco packaging cells to generate
retroviral supernatants, as previously described (Anderson et al.,
2002). The PU.1 construct was as reported previously (Anderson et
al., 2002). To generate the GATA-3 construct, restriction fragments
from two cDNAs from a mouse thymocyte library were ligated
together in the plasmid vector pBK-CMV to produce a full-length
(coding) clone. PCR amplification of the insert was then used to
introduce an EcoRI restriction site, a consensus Kozak sequence,
and the first codon of GATA-3 (ACG AAT TCC GCC ATG GAG
GTG ACT GCG) at the 5 end of the insert, and the last codon of
GATA-3, a stop codon, and a NotI restriction site (CAG CGG CCG
CTC TAA CCC ATG GCG GT) at the 3 end of the insert. The
product was digested with EcoRI and NotI, gel-purified, cloned into
the pBK-CMV plasmid vector, and sequenced before transfer into
the retroviral vector.
Retroviral Transduction of Fetal T Cell Precursors
Fetal liver cells were enriched for hematopoietic precursors,
transduced with retroviral vectors, sorted for retroviral vector
expression, and assayed for differentiation in hanging-drop or
reaggregate fetal thymus organ culture as already reported (Ander-
son et al., 2002). To obtain thymocytes for transduction, fetal
thymic lobes from E14.5 or E15.5 (C57BL/6  DBA/2) F2 embryos
were dissected and digested in 1 mg/mL T4 collagenase (Worthing-
ton) in RPMI 1640 medium at 37°C for 30–60 min to create single
cell suspensions. The thymocytes were then transduced with
retroviral supernatants by modified spin infection. The thymocytes
were plated on insert filters (Millipore; 0.4 m, 30 mm diameter)
inside six-well plates, supernatant plus 20 g/ml lipofectamine was
added, and the cells were spun (1200 rpm, Sorvall RT6000 centri-
fuge) at room temperature for 3 min. The supernatant below the
filter was removed, and the remainder of the supernatant was
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allowed to pass through the filter in the tissue culture incubator at
37°C for 15–30 min. The cells were then washed once with
DMEM-FTOC media (DMEM, 10% fetal bovine serum, 2 mM
L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 1%
nonessential amino acids, 50 M -mercaptoethanol, 20 mM
Hepes), and then either plated in tissue culture plates for 24 h in
DMEM-FTOC plus IL-7 (25 ng/ml) and Stem Cell Factor (SCF; kit
ligand, Steel factor; added as 2% supernatant from factor-producing
BHK-MKL cells), or used directly in reaggregate FTOC cultures.
BHK-MKL cells were kindly donated by Dr. Schickwann Tsai (Tsai
et al., 1994).
Fetal Thymic Organ Culture
For some experiments, retrovirally transduced thymocytes or
fetal liver cells were cultured for 24 h in DMEM-FTOC with IL-7
and SCF as above, and then sorted on a FACS Vantage (Becton
Dickinson, Foster City, CA) or Coulter Epics Elite (Beckman
Coulter) flow cytometer to isolate GFP cells as donors for fetal
thymic organ culture. In other experiments, thymocytes were
introduced into fetal thymus organ culture immediately after
transduction. Two standard methods of fetal thymic organ culture
were used (Anderson et al., 2002). For reaggregate organ cultures,
the transduced cells (4000–200,000 per sample) were combined in
volumes of 0.7 l with trypsinized stromal cells (200,000), obtained
from deoxyguanosine-treated fetal thymic lobes, and plated on
filters for culture at the air-liquid interphase. For hanging drop
reconstitution, the sorted GFP cells were placed in hanging
drop cultures in inverted Terasaki plates with undigested
deoxyguanosine-treated fetal thymic lobes (4000 donor cells/lobe)
for 48 h, and then transferred to normal fetal thymic organ cultures
as previously described (Anderson et al., 2002).
After 6–14 days of incubation, organ cultures were disaggregated
for analysis by incubation in 1 mg/mL T4 collagenase for up to 2 h
at 37°C in a tissue culture incubator. Cells were stained with
antibodies as previously described (Anderson et al., 1999) and
analyzed by using a FACSCalibur (Becton-Dickinson). The data
were analyzed by using CellQuest software.
Quantitative Real-Time RT-PCR
For analysis of gene expression effects, fetal thymocytes were
retrovirally transduced and then cultured in DMEM-FTOC for
24 h. Transduced cells were isolated by fluorescence-activated cell
sorting of GFP cells with lymphocyte-type light scatter properties,
and RNA was extracted by using the RNAzolB reagent (Leedo
Medical Inc., Houston, TX). First-strand cDNA was generated by
using Superscript RT II (Gibco/BRL Life Technology, Rockville,
MD) as previously described (Anderson et al., 1999). cDNA reac-
tions were diluted 1/100 in 10 mM Tris, pH 8.0, and used as
templates in real-time PCRs using the SYBRGreen Universal
Master Mix (P-E Biosystems, Foster City, CA), and specific primer
pairs at 5 M each. Reactions were run and analyzed by using the
GeneAmp 7700 sequence detection system (P-E Biosystems). Most
primers were designed by using Primer Express software (P-E
Biosystems). Sequences are given in Table 1. For data analysis, each
primer set was used to generate a standard curve with 10-fold
dilutions of a positive control sample, and the CT values for
experimental samples were converted to relative cDNA levels
based on the standard curve for that primer set. In most cases, the
standard curve was linear over more than three decades with a
slope close to the theoretical value of 3.3. To correct for differ-
ences in inputs among samples, results were then normalized to
equivalent levels of GAPDH and HPRT, calculated similarly from
the standard curves for those primers. The comparisons presented
are based on the normalization for HPRT levels but are not
significantly different when based on normalization for GAPDH
levels.
RESULTS
Expression of PU.1 and GATA-3 mRNA from T
Lineage Specification through -Selection
To measure expression of PU.1 and GATA-3 in the course
of T cell development, we used real-time quantitative
RT-PCR to analyze RNA in samples of thymocytes from
different developmental stages. Cell subsets were sorted to
97% purity on the basis of three or four surface markers,
from a genetically enriched starting population (Anderson
et al., 1999). The main populations from the precursor
subset of DN1 cells through DN3 cells and two post--
selection subsets were compared. These samples were also
TABLE 1
Real Time PCR Primer Sequences
PU.1-499 CCCGGATGTGCTTCCCTTAT
PU.1-619 TCCAAGCCATCAGCTTCTCC
GATA3-733 AGGCAAGATGAGAAAGAGTGCCTC
GATA3-936 CTCGACTTACATCCGAACCCGGTA
Id2-310 CCGCTGACCACCCTGAAC
Id2-381 ATAAGCTCAGAAGGGAATTCAGATG
SCL-627 CAACAACAACCGGGTGAAGA
SCL-747 ATTCTGCTGCCTCCATCGTT
Hes1-678 TCCTGACGGCCAATTTGC
Hes1-798 GGAAGGTGACACTGCGTTAGG
Myb-2304 AGCGGGAATCGGATGAATCT
Myb-2424 GAGCAGAAGAAGTTTCCCGATTT
E47-295 TTGACCCTAGCCGGACATACA
E47-415 GCATAGGCATTCCGCTCACT
c-kit-224 TGGACTTTCAAGACCTATTTCAATGA
c-kit-324 TCGTGAGGCCATTGCTGTT
IL7R-2531 CAATGAGTGCCCTACCTGAAACT
IL7R-2651 GGTTATACACAGCAGGGATTCAAA
MCSFR-2392 ATCCACCGGGACGTAGCA
MCSFR-2512 CATTGCCCTTGACAACATAGTTG
PreT-204 CTGGCTCCACCCATCACACT
PreT-324 TGCCATTGCCAGCTGAGA
Rag1-2249 GAAGCTTCTGGCTCAGTCTACATCT
Rag1-2370 ACCTCATAGCGCTGCAGGTT
Rag2-903 ACAGTCTTGCCAGGAGGAATCTC
Rag2-1023 CAAGGCTGCAGACCATCCTT
GAPDH-189 ACTCCACTCACGGCAAATTCA
GAPDH-309 GCCTCACCCCATTTGATGTT
HPRT-2F GAGCTACTGTAATGATCAGTCA
HPRT-2R ACCAGCAAGCTTGCAACCTT
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contrasted with three other subsets of DN1 cells (Wang et
al., 1998; Anderson et al., 1999; Telfer and Rothenberg,
2001; H. Wang, M. Yui, R. A. Diamond, and E.V.R., unpub-
lished observations) that differ in T lineage precursor activ-
ity. The only DN1 subset with high T cell precursor
activity consists of the Sca-1 HSA Thy-1 cells (M. A.
Yui, R. A. Diamond, and E.V.R., unpublished observations),
shown in the fourth column of DN1 cells in Fig. 2 (aster-
isks). Figure 2 shows the relative levels of GATA-3 and
PU.1 RNA in these cells.
GATA-3 RNA levels are maintained at a remarkably
constant level throughout T cell development to the DP
stage (Fig. 2, upper panel). There is one exception: a subset
of adult DN1 cells, the Sca-1 Thy-1 cells, which express
about seven to eight times more GATA-3 mRNA than the
other cell types. However, these cells appear to be unable to
differentiate into DN2 or DN3 T lineage cells, in direct
tests of developmental potential (M. A. Yui, R. A. Diamond,
and E.V.R., unpublished results), so their significance is
unknown. Other subsets of DN1 cells which appear natural
killer-like (Fig. 2, first and second columns; Wang et al.,
1998; Telfer and Rothenberg, 2001), resemble the T cell
precursors in their expression of GATA-3. The stability of
GATA-3 RNA expression throughout T lineage specifica-
tion and commitment has been substantiated in an exten-
sive series of additional measurements by using semiquan-
titative RT-PCR techniques (H. Wang, R. A. Diamond, and
E.V.R., unpublished observations). In the mainstream of T
cell development, GATA-3 RNA only rises modestly after
-selection, to an approximate two times higher level in the
DP cells. In addition, GATA-3 protein levels appear to
increase transiently in the late DN stages after -selection
(G.H.-H., M.K.A., and E.V.R., unpublished observations).
Elsewhere, we show that GATA-3 RNA expression in-
creases more substantially in later stages of the develop-
ment of certain T cell subsets.
PU.1 RNA levels follow a contrasting pattern. The high-
est levels of PU.1 are found in the T lineage precursor-
enriched subset of DN1 cells (Sca-1 Thy-1). These levels
drop about seven to eight times in the DN2 stage, and fall
another fivefold to near background in the subsequent
postcommitment stages. As a result, the ratio of PU.1 to
FIG. 2. Relative mRNA levels of GATA-3 and PU.1 in developing
thymocytes as assessed by quantitative real-time RT-PCR. Devel-
opmentally staged thymocyte subsets were sorted as previously
described (Anderson et al., 1999) from RAG-2/ mice (columns
1–6), normal C57BL/6 mice (column 7), or C57BL/6 congenic mice
deficient in both class I and class II major histocompatibility
complex expression (column 8). The DN1 population was defined
as HSA and subfractionated by Sca-1 and Thy-1 expression as
indicated in the figure. The DN2 sample consisted of Sca-1 HSA
CD44 cells, the DN3 sample consisted of Sca-1 HSA CD44
cells, the ISP population consisted of CD8 CD3 cells, and the DP
population consisted of preselection CD4 CD8 cells. First-strand
cDNA products from these populations were amplified with prim-
ers for GATA-3 (upper panel) or PU.1 (lower panel) by real-time
quantitative PCR. The relative mRNA levels were normalized to
HPRT levels and displayed in arbitary units.
FIG. 3. Stages at which overexpression of PU.1 blocks ability of fetal liver-derived precursors to differentiate to T cells in fetal thymic organ
culture. (A) Comparison of cell types produced in fetal thymic organ culture by fetal liver-derived hematopoietic precursors, transduced either
with empty LZRS vector as a control or with PU.1. Transduced cells were incubated in fetal thymic organ culture for differentiation for 5 days
after hanging-drop reconstitution. Left panels show distribution of vector-expressing (GFP) cells with varying levels of expression of the T
lineage marker, Thy-1. Central and righthand panels show the distributions of the Thy-1low and Thy-1 GFP cells in each population as separated
into DN1, DN2, and DN3 subsets by the markers CD44 and CD25. DN1 cells (Thy-1low and Thy-1) are found in the upper left (CD44 CD25)
quadrants of these plots. DN2 cells are found in the upper right (CD44 CD25) quadrants. DN3 cells are found in the lower right (CD44 CD25)
quadrants. At this time point, DN4 cells (lower left quadrant) have not been generated in either sample. (B) Schematic summary of stages when
PU.1 overexpression inhibits developmental progression. Darkly shaded circles indicate cell types that are produced without inhibition. Lightly
shaded circles are cell types that are generated, but in reduced numbers. Unfilled circles with broken outlines indicate cell types that are not
generated from these precursors when PU.1 is overexpressed. Data are from Anderson et al. (2002).
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FIG. 4. Overexpression of GATA-3 in fetal liver-derived hematopoietic precursors results in a partial block in early T cell development.
A comparison of the differentiation of fetal liver precursors for 7 (A) or 10 days (B) in fetal thymic organ culture after transduction with an
empty control retroviral vector (LZRS) or vector-encoding GATA-3. Transduced fetal liver precursors were used to reconstitute
deoxyguanosine-treated fetal thymic lobes in fetal thymic organ culture. The lobes were then disaggregated and analyzed by flow cytometry
at Day 7 (A) or Day 10 (B) of culture. The plots on the left of each panel are gated on live cells (black); the numbers above the gates give
the percentage of cells within each gate. Donor-type cells in each experiment were detected by the GFP fluorescence from the retroviral
vectors, and the GFP cells were distinguished into Thy-1low and Thy-1 populations. The two fractions of GFP cells (Thy-1low and Thy-1)
in each sample were further analyzed by CD44 and CD25 expression as shown in the plots on the right of each panel, which are gated on
the GFP cells (green) with Thy-1 levels as indicated. The developmental progression normally corresponds to a clockwise rotation through
the CD44/CD25 quadrants from the upper left quadrant (DN1) to the lower left quadrant (DN4). Control cells by day 7 are primarily Thy-1
and concentrated in the DN3 population (lower right quadrants of CD44/CD25 plots). By day 10, controls include many DN3 cells as well
as cells passing through -selection (Thy-1 cells shifting from lower right quadrant to lower left quadrant of CD44/CD25 plots). The
GATA-3-transduced cells fail to generate Thy-1 DN3 cells and tend to remain in the “DN1” quadrant (upper left quadrants of CD44/CD25
plot); however, some cells apparently in -selection are seen in these samples at day 10 (B). Note that the numbers of cells displayed in
individual CD44/CD25 plots are scaled for visibility and do not reflect the relative numbers of GFP cells among samples.
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FIG. 5. Reduced impact of GATA-3 overexpression in E14.5 fetal thymocytes: comparison with PU.1. Fetal thymocytes, which are mostly
in the late DN stages at E14.5–E15.5, were transduced with LZRS control retroviral supernatant (A, B), GATA-3-encoding retroviral
supernatant (A), or PU.1-encoding retroviral supernatant (B). The cells were then used to reconstitute deoxyguanosine-treated fetal thymic
lobes and analyzed after approximately 1 week in organ culture. The plots on the left are gated on live cells (black), and percentages of GFP
cells are indicated above the gates. The plots on the left are gated on GFP cells (green) and measure progression from the DN (lower left
quadrants) to the CD4 CD8 (DP) stage (arrows in upper right quadrants) and survival at that stage and beyond. (A) E14.5 fetal thymocytes
were transduced with LZRS or GATA-3 and sorted for GFP cells before use as donors in fetal thymic organ culture. (B) E15.5 fetal
thymocytes were transduced with LZRS or PU.1 and used to reconstitute reaggregate fetal thymic organ cultures without prior sorting. An
experiment with PU.1 similar to that in (A), using E14.5 fetal thymocytes and sorting before culture, yielded even fewer GFP cells but a
qualitatively similar result. Note that the numbers of cells displayed in the right panels are scaled for visibility and do not reflect the
relative numbers of GFP cells among samples.
FIG. 6. Distinct time windows for effects of GATA-3 and PU.1 overexpression on T cell development. The figure shows a schematic
summary of the effects on recovery of cells in the indicated stages of T cell development when precursors are forced to overexpress GATA-3
(black curve) or PU.1 (red curve). The summary is based on combined data from experiments using fetal liver precursors for transduction,
as in Figs. 3 and 4 and in Anderson et al. (2002), and from experiments using fetal thymocytes for transduction, as in Fig. 5. Fetal liver
precursor transduction allows measurements of effects of factor overexpression on the earlier stages of development shown in the figure
(roughly, to DN2/3 stages), while transduction of E14.5–E16.5 fetal thymocytes allows measurements of effects from the late DN stages
through the DP stage and beyond (Fig. 4) (G.H.H. and M.K.A., data not shown). Note that the relative severities of the effects of the two
perturbations cross at about the -selection checkpoint. The gray rectangle indicates the crucial interval from specification to -selection,
corresponding to the DN2 and DN3 stages, which is a focus of differential effects of PU.1 and GATA-3. This interval is marked by a unique
transcription factor expression pattern (Rothenberg et al., 1999; Rothenberg, 2000) and a strong dependence on IL-7R for proliferation and
survival (Di Santo et al., 1999; Haks et al., 1999).
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GATA3 expression, at least at the RNA level, shifts from a
relatively high value in the precursor population to a very
low value in the DN3 cells immediately preparing for
-selection.
Effect of GATA-3 Overexpression in T Cell
Precursors: Contrast with PU.1
GATA-3 and PU.1 knockout mice have hematopoietic
defects which make it difficult to measure the specific ways
that losses of these activities interfere with T lineage
development. Technical factors currently prevent any sys-
tematic comparisons of losses of transcription factor func-
tion at different stages of T cell development before
-selection. However, because of the dose-dependent shifts
in activity of these factors, overexpression also can perturb
T cell development, doing so in ways that depend on
regulatory context. The types of perturbations caused by
overexpression at different stages can indicate the limits of
the regulatory states that are permissive for T lineage
specification. This work therefore focuses on defining the
time courses and mechanisms of high dose-dependent in-
terference by these factors.
We have previously shown that overexpression of PU.1
using GFP-containing bicistronic retroviral vectors in E14.5
fetal liver precursors has three major effects on their devel-
opment in fetal thymic organ culture, as diagrammed in Fig.
3A (Anderson et al., 2002). The first effect is a severe
decrease in PU.1-expressing cell numbers, and the second
effect is a reduction in the number of cells that acquire
surface Thy-1 expression during the first week of culture,
relative to vector-only controls. The third effect is that the
cells fail to progress through -selection. The cells express-
ing the highest levels of PU.1 are prevented from entering
the lymphoid developmental pathway(s) at all; these cells
may differentiate directly into myeloid cells or die. The
cells that do become Thy-1 are able to differentiate into
the CD25 DN2 and DN3 stages (an example shown in Fig.
3B), but these CD25 cells can tolerate only low levels of
ectopic PU.1 as measured by mean fluorescence of the
coexpressed GFP reporter (Anderson et al., 2002). The
ability of PU.1 to interfere with GATA function in some
systems (Rekhtman et al., 1999; Zhang et al., 2000), in
combination with the devastating effects of the loss of
either of these factors in early T cell development, sug-
gested that a PU.1–GATA interaction may be crucial for
successful transition of precursors into the T cell lineage.
To test whether higher levels of GATA-3 expression in
early precursors could enhance T cell development by
facilitating entry into the T lineage, we constructed bicis-
tronic retroviral vectors for expression of GATA-3 and GFP
from the same mRNA, and used these to ectopically express
GATA-3 in E14.5 fetal liver cells. The GFP-expressing cells
were then introduced into fetal thymic organ culture for
differentiation, essentially as we have described previously
for PU.1 (Anderson et al., 2002). The results were unam-
biguous. As shown in Fig. 4A, GATA-3 transduction did not
enhance T cell development relative to control populations
transduced only with the empty LZRS vector. Instead, it
severely arrested thymocyte differentiation at the earliest
transition associated with specification. This effect went
well beyond the general antiproliferative effects that we
have observed with a variety of overexpressed transcription
factors (Anderson et al., 2002; M.K.A., G.H.H., C.D., and
A.M.A., unpublished observations). Not only did GATA-3
prevent the appearance of DN2 or DN3 cells, but also it
prevented most of the DN1 cells from acquiring Thy-1
expression. The severity of this effect contrasts markedly
with the effect of PU.1, which although antiproliferative,
permits readily detectable production of Thy-1 DN2 and
DN3 stage cells in most cases before T cell development is
completely blocked (cf. Fig. 3B) (Anderson et al., 2002).
Thus, contrary to expectation, GATA-3 blocked T cell
development more severely at an earlier stage than PU.1.
Most precursors transduced with GATA-3 never signifi-
cantly repopulated the host thymic lobes, even after pro-
longed incubation (data not shown). However, processing
each repopulated thymic lobe separately for fluctuation
analysis, we detected some establishment of GATA-3-
transduced cells in a minority of the lobes in two out of
three experiments. A representative of these minority cases
is shown in Fig. 4B. Survival and Thy-1 acquisition were
correlated with low GFP expression, suggesting that the
cotransduced GATA-3 gene was only tolerated in such cells
at a low level. Some cells with low-level expression of the
vector eventually showed surface marker expression pat-
terns suggesting that they were undergoing -selection (Fig.
4B, i.e., Thy-1 GFPlow cells with CD44 CD25 or CD25low
phenotypes), and in one atypical sample, some DP cells
were generated (data not shown; in this sample 5% of the
surviving cells were GFP, but the levels of expression were
unusually low). Thus, in the rare cases where GATA-3-
transduced cells could survive in the thymus at all, they
showed no evidence of encountering an additional block to
differentiation at the -selection check point.
Time Windows for GATA-3 and PU.1
Misexpression Effects
Further evidence that GATA-3 and PU.1 effects diverge
around the time of -selection was found when these genes
were transduced into E14.5 fetal thymocytes instead of fetal
liver cells (Fig. 5). These are cells that have already under-
gone at least 2 days of T cell development in the thymus
and represent a spectrum of developmental stages from the
earliest precursors to cells actively engaged in TCR gene
rearrangement. When these cells were reintroduced into
fetal thymic organ culture after transduction to continue
their differentiation, control vector-transduced cells (LZRS)
differentiated into DP thymocytes (Fig. 5A) and more ma-
ture thymocytes within a week.
As shown in Fig. 5A, GATA-3 overexpression had a much
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less severe effect on survival of these fetal thymocytes (left
panels, only 4- to 5-fold difference in percentages in GFP
populations) than on the intrathymic development of fetal-
liver derived precursors as shown in Fig. 4 (15- to 30-fold
difference or greater). Although they appeared to expand
less than controls in the DN-to-DP transition, GATA-3-
transduced cells also displayed the light scatter properties
of lymphoblasts (Fig. 5A, left), consistent with proliferation
after -selection. They also generated a significant popula-
tion of DP cells (arrow in Fig. 5A) with a few more-mature
“single-positive” CD4 or CD8 cells. Thus, at least for a
short period after -selection, the severity of GATA-3
effects was much reduced. This interpretation is supported
by similar results, using human lymphoid precursors, in a
study focused on stages from -selection onward (Taghon et
al., 2001).
A similar test of PU.1 transduction into fetal thymocytes
showed that PU.1 remains intensely inhibitory to the
survival or proliferation of fetal thymocytes. E14.5 thymo-
cytes, just before -selection, could hardly be recovered at
all after transduction, and E15.5 thymocytes, which include
a few cells that have already rearranged their TCR genes,
were also severely inhibited (Fig. 5B; 25-fold difference in
percentage of GFP cells between PU.1-transduced and
controls). Overexpression of PU.1 does not perceptibly
enrich for large lymphoblasts that might be generated
during -selection (Fig. 5B, left). There was no evidence that
-selection provides temporary or longer-term protection
from the inhibitory effects of PU.1 overexpression, in con-
trast to those of GATA-3 overexpression.
The effects of overexpressing the two transcription fac-
tors on T cell development are compared schematically in
Fig. 6. When expressed from the prethymic fetal liver
precursor stage onward, PU.1 expression moderately im-
pedes progression through the DN2 and DN3 stages, but
allows little if any passage beyond. On the other hand,
GATA-3 overexpression severely restricts entry into the
DN2 and DN3 stages, but its effect seems to moderate in
any surviving cells that trickle through to -selection.
Thus, GATA-3 is not simply a rate-limiting positive regu-
lator of T cell development, but rather a factor with
distinctive dose- and time-dependent effects in T cell de-
velopment that can inhibit when applied in the wrong
developmental interval.
Monitoring of Target Genes Affected during
Transcription Factor Overexpression
To address the mechanisms perturbed by PU.1 and
GATA-3 overexpression, we initiated a series of studies to
determine which known, developmentally relevant target
genes might be altered in expression in the transduced cells.
The genes were chosen to provide possible explanations for
the cause of the developmental arrests, and to reveal
whether the misexpressed transcription factors were simply
killing T cell precursors or driving the cells toward a
competing developmental pathway. To sample effects on a
wide range of genes that are expressed before -selection in
primary fetal T cell precursors, we transduced PU.1 or
GATA-3 into E14.5 fetal thymocytes and analyzed the
RNAs expressed in the transduced cells 24 h later. This
early time point was chosen because little differential cell
loss has occurred at this stage, although some phenotypic
effects are already manifest: for example, the fraction of
cells expressing the cell-surface myeloid markers Mac-1
(CD11b) and M-CSF-R is increased in the PU.1-transduced
population and reduced in the GATA-3-transduced popula-
tion (M.K. Anderson, data not shown). The results are
shown below in Table 2 and illustrated in Figs. 7 and 8.
The data shown are subject to certain limitations. First,
the analysis at 24 h is likely to give only the initial
indications of effects that overexpression will later bring
about, because of the delay between transduction and
translation of retrovirally encoded genes. The early time
point used here was chosen to give most selective access to
direct regulatory targets of transcription factor perturba-
tion, but at the potential cost of quantitative impact.
Second, the RNA-based analyses used to maximize sensi-
tivity do not address the potential roles of differential
protein translation, stability, or posttranslational modifica-
tions such as acetylation or phosphorylation, all of which
are obviously important for the regulatory functions of
these genes. However, because the genes being overex-
pressed are transcription factors, measuring changes in
mRNA levels provides a read-out of the potential functions
of these factors within each context examined. Finally, at
day 14.5 of gestation, the fraction of fetal mouse thymo-
cytes at each developmental stage can vary from litter to
litter, causing variability in response in different experi-
ments. This source of variability should be overcome in
principle by analysis of highly defined, purified subsets,
which are challenging to obtain in reasonable quantities.
However, the aggregate data from independent experi-
ments, given in Table 2, are best represented by an experi-
ment in which Thy-1 and Thy-1 subsets of transduced
cells were analyzed separately (Table 2, Exp. 1). In this
separation, the Thy-1 fraction includes primarily the DN2
and DN3 stages (CD25) and cells undergoing -selection,
while the Thy-1 fraction includes the DN1 precursors and
unspecified cells. These results are highlighted in Figs. 7
and 8.
Initial Definition of a Set of Target Genes Affected
by PU.1 Overexpression
One day after transduction with a PU.1 expression con-
struct, the transduced cells contain substantially more
PU.1 RNA than normal fetal thymocytes on the average
(Table 2), with ratios that are strongly influenced by the
35–40 drop in endogenous PU.1 expression between the
Thy-1low and Thy-1 stages of fetal thymocyte differentia-
tion (Table 2, Exp. 1, Control). Transduced levels of PU.1
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RNA are 1.5- to 10-fold higher than the endogenous levels
in control Thy-1low fetal thymocytes transduced with the
empty LZRS vector alone (Table 2, Exps. 1 and 5).
PU.1 overexpression rapidly affects expression of several
genes needed for TCR expression and survival in fetal
thymocytes. A strong and reproducible negative regulatory
impact on Rag-1 and Rag-2 expression was seen in these
fetal thymocytes (Fig. 7A, lower panels). This result con-
firms earlier data obtained when PU.1 was introduced into
the DN3-like SCID.adh cell line (Anderson et al., 2002).
Overexpression of PU.1 also reproducibly causes moderate
inhibitions of expression of the transcription factors, HES-1
and c-Myb (Fig. 7A, right panels; results from Exps. 1 and 2,
Table 2, are shown together in the figure), which are
normally upregulated between the Thy-1low and Thy-1
stages (Fig. 7A). These effects are of considerable interest
because both HES-1 and c-Myb genes are essential for T cell
development (Tomita et al., 1999; Kaneta et al., 2000; Allen
et al., 1999). The loss of recombinase and the downregula-
tion of these genes could account for the reduced number of
T cell precursors and the block at -selection in PU.1-
transduced populations.
Other T lineage genes, in contrast, were less affected or
less consistently affected. In the fetal thymocyte context,
PU.1 transduction did not inhibit the expression of preT,
the invariant component of the pre-TCR, and instead con-
sistently gave a slight elevation of preT transcript levels,
which was confined to the Thy-1 and/or CD25 cells that
normally express this gene (Fig. 7A). PU.1 had a modest
negative effect, if any, on the expression of the lymphocyte-
specific growth factor receptor IL-7R, and the characteris-
tic growth factor receptor of immature hematopoietic cells,
c-kit. In some experiments, PU.1 appeared to inhibit
GATA-3 expression as well (Table 2).
Possible transdifferentiation influences were difficult to
detect due to the background of cells expressing “myeloid-
TABLE 2
Quantitation of RNA Levels in E14.5 Fetal Thymocytes Overexpressing PU.1 or GATA-3
Exp. Sort Sample PU.1 GATA-3 Id-2 SCL Hes-1 Myb E47 c-kit IL7R MCSFR PreT Rag-1 Rag-2
1 Thy1 Control 0.22 9.1 1.4 0.08 9 11.9 23.2 8.8 2.7 0.4 5 6.2 16
PU.1 88 2.4 1.4 0.23 2.2 3.4 11.1 3.8 1.1 0.7 8.2 1.1 4.1
GATA-3 0.07 140 1.1 0.5 6.9 7.1 8.6 13.7 0.3 0.2 1.2 1.6 4.3
Thy1 Control 8 2.6 3.8 2.3 2.1 2.8 7.5 9 0.6 4 0.04 0.07 0.8
PU.1 34 1 5.1 1.2 0.5 0.6 4.2 4.5 0.3 3.4 0.06 0.008 0.2
GATA-3 1.5 55 1.5 5.2 4.9 5.9 5.7 12.5 0.1 0.3 0.004 0.02 0.5
2 CD25 Control 0.4 0.8 0.7 0.12 1.4 9 4.4 3.8 1.5 0.3 3.3 3 4.7
PU.1 56 1.1 1.1 0.3 0.6 2.9 7.9 4.4 0.8 0.8 6.7 0.8 2.1
CD25 Control 0.5 ND ND 0.26 ND 9.8 ND ND ND ND 3.1 3.4 6.7
PU.1 74 ND ND 0.34 ND 2.9 ND ND ND ND 6.1 0.7 2.2
3 GFP Control 5.3 1.4 2.5 2 3.7 11.6 4.2 ND 1.7 ND 6 8.5 15
GATA-3 0.8 19 1.8 6.9 14.1 8.7 1.8 ND 0.5 ND 3.1 2.7 4.9
4 GFP Control 1.4 2.7 1.2 1.2 2 7.1 5.1 9.1 2.1 1.5 2.5 2.8 4.5
GATA-3 0.8 241 4.4 1.2 5.9 7.8 7.6 29.4 2.1 0.5 0.7 1.4 2.2
5 Thy1 Control 0.3 9 0.9 0.9 1.1 4.7 5.2 7.1 2.1 0.2 7.2 ND ND
PU.1 22.4 2 0.7 0.6 0.4 1.2 2.7 2.5 2.9 0.2 19.1 ND ND
GATA-3 0.1 320 0.5 2.9 4 6.4 5.5 17.5 1.4 0.1 4 ND ND
Thy1 Control 1.4 2.8 2.4 2.5 0.1 9 3.1 3.9 1.3 4.2 0.2 ND ND
PU.1 2.1 0.5 1.3 0.6 0 2 1.4 1.2 0.4 1.8 0.08 ND ND
GATA-3 0.2 85.7 0.8 13.4 1.1 26 3.1 12.1 0.7 0.4 0.06 ND ND
Note. Relative RNA levels normalized between samples by HPRT and/or GAPDH values are shown. Units for each gene are adjusted to
a range around 1–10: thus, values in the table for different genes cannot be compared directly. In experiments 1–4, GFP cells were sorted
for analysis 24 h after transduction with empty LZRS vector (control) or with the indicated construct; in experiment 5, GFP cells were
sorted 36 h after transduction. In experiment 4 only, the average values for GFP cells in three samples were taken as the control. In
experiments 1, 2, and 5, GFP cells were also selected on the basis of surface phenotype. Thy-1 cells are concentrated in the DN1
population, while Thy-1 cells are likely to be dominated by DN3 cells, cells passing through -selection, a smaller number of DN2 cells,
and a fraction of the DN1 cells. CD25 cells, specifically collected in the two samples in experiment 2, define the DN2 and DN3 subsets.
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associated” markers in the fetal thymus. As noted above,
the minority population(s) that express cell-surface
M-CSF-R and/or Mac-1 were often expanded in PU.1-
transduced populations (Anderson et al., 2002; and data not
shown); however, these population shifts did not have a
consistent detectable impact on normalized M-CSF-R RNA
levels. Some effects of PU.1 transduction could have been
partly masked by dilution, or by the strong decreases in
M-CSF-R and Id2 expression that occur normally in the
fetal thymocytes between the Thy-1 (DN1-like) and
Thy-1 (DN2/3 and later) stages.
Target Genes Affected by GATA-3 Overexpression:
Comparison with PU.1 Targets
A parallel analysis of the impact of GATA-3 overexpres-
sion revealed a different set of targets, as shown in Fig. 7B
and Table 2. In these transduced cells, GATA-3 RNA
expression levels were typically elevated 15–20 over con-
trols transduced with empty vector (Table 2); Western
blotting of samples from a similar experiment showed
24 overexpression at the protein level (G.H.-H., data not
shown). GATA-3 overexpression consistently caused a se-
vere inhibition of PU.1 expression and coordinate down-
regulation of the genes preT, Rag-1, and Rag-2, which are
characteristically expressed in the DN2 and DN3 stages
(Fig. 7B, lower panels and upper right panel; results from
exp. 1, Table 2, are shown). However, HES-1 and c-Myb
were unaffected or enhanced in expression, in contrast with
PU.1-transduced cells (Fig. 7B; Table 2). Strikingly, GATA-3
overexpression also sharply inhibited expression of the
lymphocyte growth factor receptor IL-7R, downregulating
its mRNA accumulation levels in both Thy-1low and Thy-1
subsets of thymocytes (Fig. 7B, center panel; and Table 2).
This target could substantially account for the stage-
specificity of GATA-3 effects, as discussed below.
The spectrum of gene expression changes in GATA-3-
overexpressing cells suggests that key functions for devel-
opmental progression of the DN2–DN3 Thy-1 cells are
disabled. Meanwhile other cells are actively restrained or
diverted from myeloid development. For example, GATA-3
overexpression in thymocytes decisively downregulated the
myeloid growth factor receptor M-CSF-R, which is typically
expressed at high levels in Thy-1 cells (Fig. 7B, top center).
This result is consistent with the known repressive effects
of GATA-1 and GATA-3 on macrophage and neutrophil
development (Chen and Zhang, 2001; Zhang et al., 1999;
Kulessa et al., 1995).
In previous work with stem cells purified from bone
marrow (Chen and Zhang, 2001), GATA-3 blocked lympho-
cyte and myeloid (macrophage and granulocyte) develop-
ment while promoting differentiation of c-kit megakaryo-
cytes in vitro and megakaryocytes and erythroid cells in
vivo. There, its effects were apparently being interpreted as
a proxy for GATA-1. It is therefore noteworthy that, even in
our transductions of fetal thymocytes, GATA-3 consis-
tently induced upregulation of two genes used in
megakaryocytes and stem cells, c-kit and SCL (Tal-1).
Expression of c-kit in T cell precursors is normally down-
regulated at the Thy-1 DN3 stage and expression of SCL is
normally shut off during the Thy-1 DN2 cell stage (Her-
blot et al., 2000). GATA-3 overexpression upregulated these
genes not only in Thy-1low cells but also in Thy-1 cells (Fig.
7A; Table 2).
Figure 8 provides a comparative summary of the effects of
PU.1 and GATA-3 overexpression, focusing specifically on
the Thy-1 cells which are most likely already to be
specified for a T lineage fate. Even in these cells, the results
can account for the inhibitory effects of the two factors and
reveal differences between the ways that their overexpres-
sion constrains T cell development. Both factors block the
functions involved in TCR gene rearrangement, but PU.1
interferes with specific survival functions mediated by
HES-1 and c-Myb, while GATA-3 spares these genes but
inhibits the stage-specific survival functions of IL-7R.
DISCUSSION
Different Temporal Windows for PU.1 and GATA-
3 Action in T Lineage Specification
The results presented here establish that the essential T
lineage factor, GATA-3, is drastically inhibitory to T cell
development if overexpressed in hematopoietic precursors
before TCR gene rearrangement. Our data distinguish two
phases of perturbation sensitivity in early thymocyte differ-
entiation, one in which development is more severely
inhibited by GATA-3 and a subsequent, though overlap-
ping, one in which development is more severely inhibited
by PU.1. PU.1 is required for T cell development only at the
earliest stage, in a hit-and-run fashion, and it is not surpris-
ing that it interferes with development when forced to be
expressed out of temporal context. However, GATA-3 is
essential from the first stages and used throughout T cell
development; thus, its ability at higher levels to inhibit the
same early stages indicates that only low-dose expression is
tolerated in the stages before -selection.
The same level of GATA-3 overexpression has signifi-
cantly less impact as the cells pass -selection. T cell
development must be routed through a distinct regulatory
state, represented by the DN2 and DN3 stages, before this
key positive regulator may be used freely in a wider con-
centration range. The different cofactors available as differ-
entiation proceeds presumably shift the repertoire of effects
GATA-3 and PU.1 can have. For example, the transcrip-
tional regulators SCL and Id-2 are expressed at high levels in
DN1 cells but at much lower levels, if at all, in DN2/3 cells,
whereas HES-1 and E2A are at low levels in the DN1 cells
and upregulated in the DN2/3 cells (Herblot et al., 2000;
M.K.A., E.-S. David, and E.V.R., unpublished data). It is of
interest that our data show that these coregulators may
themselves be regulated, in part, by GATA-3 and PU.1.
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FIG. 7. Examples of changes in mRNA levels after 24 h of GATA-3 or PU.1 overexpression in E14.5 fetal thymocytes. The figure illustrates
developmental comparisons between gene expression levels in the most immature thymocytes (Thy-1low, mostly DN1 cells) and cells that are more
advanced in T lineage development (Thy-1, mostly DN2 and DN3 cells and possibly some later stages), and comparisons between the effects of PU.1
(A) and GATA-3 (B) overexpression in these shifting cellular contexts. The data represent a selection from the analyses shown in Table 2, focusing on
experiments where the overall viability of transduced cells was highest and the results most representative. E14.5 fetal thymocytes were transduced
with the indicated constructs (Control, transduced with LZRS vector only), cultured in IL-7 and SCF for 24 h, and then sorted to isolate GFP cells with
the indicated Thy-1 or CD25 expression characteristics. First-strand cDNA was synthesized from RNA of each sample and subjected to quantitative
real-time PCR. Data are from Table 2, experiment 1 (Thy-1 and Thy-1 cells; A, B) and experiment 2 (CD25 cells; B; corresponding to DN2 and DN3
cells). All levels are normalized to HPRT levels. Scales for each graph are chosen arbitrarily to display the relative magnitudes of the mRNA levels and
differ among panels.
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Distinct Mechanisms of Developmental Arrest by
GATA-3 and PU.1 Overexpression
Our analysis of GATA-3 target genes in thymocytes
suggests two kinds of mechanisms through which GATA-3
overexpression could be having its surprisingly severe ef-
fects. One could be that it aborts development after T
lineage specification, by directly or indirectly causing re-
pression of IL-7R, Rag-1,2 recombinase components,
preT, and PU.1. IL-7R is a noteworthy target of GATA-3
inhibition, because the stages of T cell development most
clearly affected by GATA-3 overexpression correspond to
the stage of maximal IL-7R-dependent proliferation (Di
Santo et al., 1999). Another developmental mechanism
through which high-dose GATA-3 could act may operate
even earlier. GATA-3 overexpression might divert uncom-
mitted cells away from a lymphoid precursor fate alto-
gether, as shown in purified hematopoietic stem cells from
bone marrow (Chen and Zhang, 2001). More recent experi-
ments have confirmed that fetal liver precursors, too, are
skewed to megakaryocytic and/or erythroid phenotypes
when GATA-3 is overexpressed (D.C., data not shown).
Such inappropriate differentiation of fetal liver precursors
could be taking place in our fetal thymus organ cultures,
which do not provide growth factors to support survival and
recovery of megakaryocytic cells.
The loss of lymphoid and myeloid progeny cells could be
due to inhibition of PU.1 (Scott et al., 1994; McKercher et
al., 1996). GATA-3 could block expression of target genes
positively regulated by PU.1, either through its direct
repression of PU.1 RNA expression or through its ability,
like other GATA proteins, to block transactivation by PU.1
protein (Zhang et al., 1999; Nerlov et al., 2000). The
phenotype of the GATA-3 overexpressing thymocytes is
strikingly reminiscent of that of the rare thymocytes in
PU.1/ mice (Spain et al., 1999). Effects on PU.1 or its
relative, Spi-B, could even underlie the effects of GATA-3
on IL-7R, for recent data show that this can be a positive
target of PU.1 at physiological levels, at least in B lineage
cells (Scott et al., 1997; DeKoter and Singh, 2000; DeKoter
et al., 2002).
PU.1 overexpression blocks T cell development in a way
that differs from GATA-3 overexpression in its relative
sparing of IL-7R expression and its reproducibly repressive
effects on genes encoding the two critical transcription
factors, HES-1 (mammalian homolog of Enhancer of split)
and c-Myb. These effects are consistent with the expression
patterns of HES-1 and c-Myb (H. Wang, R.A. Diamond, and
E.V. Rothman, unpublished observations), which are up-
regulated at the DN13DN2 transition as PU.1 levels
decrease. HES-1 is the transcription factor that mediates
much of the needed role of Notch1 signaling at these early
stages, and it is particularly important for proliferation in
DN2 to DN3 stages. In fact, the PU.1 overexpression
phenotype in the thymus is almost completely duplicated
by the phenotype of HES-1/ lymphoid precursors (Tomita
et al., 1999). The role of c-Myb in the DN2 and DN3 stages
is less clear. However, the ability of PU.1 overexpression to
shut off Rag-1 and Rag-2 expression is just as potent as that
of GATA-3 overexpression. With less inhibition of IL-7R
than in GATA-3-transduced cells, the PU.1-transduced
cells could encounter a more abrupt block at -selection to
give the effects seen.
Taken together with previous work (Anderson et al.,
2002), our results suggest a distinction between two classes
of PU.1 overexpression effects: those that interfere with T
cell developmental progression, and those that activate and
commit the cell to a competing myeloid-like program. In
previous experiments with the DN3-like SCID.adh cell
line, PU.1 transduction led to downregulation of preT
generally and upregulation of Id2 and Mac-1 (CD11b) in a
subset of the most highly expressing cells. These effects are
not conspicuous in thymocytes at the RNA level, at least
not within 24 h. The results imply that T lineage develop-
mental arrest does not depend on myeloid transdifferentia-
tion. However, analysis of cell surface markers using flow
cytometry indicates that PU.1 induces Mac-1 and MCSFR
on a minority of fetal thymocytes in a time-dependent
manner, with small increases over control levels seen at
24 h and larger effects manifest by 36 h (Anderson et al.,
2002; and data not shown). Under certain conditions, there-
FIG. 8. Comparison of effects of PU.1 and GATA-3 overexpres-
sion on mRNA levels in Thy-1 fetal thymocytes. Parallel and
divergent effects of PU.1 and GATA-3 expression are compared in
a restricted developmental compartment, the Thy-1 fraction of
E14.5-transduced thymocytes. Changes in mRNA expression in
experimentally transduced cells relative to control cells transduced
with LZRS vector alone (GATA-3/LZRS or PU.1/LZRS) are
shown on a logarithmic scale to display the magnitudes of negative
as well as positive effects. Light bars, changes in samples trans-
duced with GATA-3. Dark bars, changes in samples transduced
with PU.1. The results shown are from Table 2, experiment 1.
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fore, certain Thy-1 DN2 and/or DN3 cells do appear to
retain an ability to respond to high levels of PU.1 with a
differentiative response instead of death. We are actively
investigating the relationship between this induced plastic-
ity and the onset of T lineage commitment.
Potential Relationship of GATA-3 and PU.1
Overexpression Effects to Normal Roles
Overexpression experiments in general introduce two
sorts of artifacts: transcription factor engagement of low-
affinity target sites, and the action of one transcription
factor on genes that are physiologically the targets of other
factors of the same family. As already noted, GATA-3
overexpression in hematopoietic stem cells appears to be
interpreted as an increased activity of its family members,
GATA-1 and/or GATA-2. To some extent, this may explain
the tremendous loss of cells with T lineage precursor
activity from a starting population of pluripotent fetal liver
cells upon overexpression of GATA-3. However, this can-
not explain the effects in cells that are already T lineage-
specified, such as fetal thymocytes, which do not express
other GATA family members. In fact, the gene expression
abnormalities observed in these cells, such as loss of recom-
binases, preT, and IL-7R expression, are reminiscent of
events that occur normally during -selection, when
GATA-3 RNA and protein levels do rise. Though these
effects are harmless after TCR gene rearrangement, they
can abort T cell development completely if they occur
prematurely. Thus, it is possible that the mechanism
through which GATA-3 arrests DN2/3 thymocyte differen-
tiation is a heterochronic imposition of aberrant -selection
(Taghon et al., 2001).
The key question is how far the effects of GATA-3
overexpression in our studies deviate from any normal
response. Here, there are hints that the natural positive
regulators of GATA-3 expression in thymocytes can drive
its expression to levels that can mimic aspects of our
overexpression results, when they are not held in check.
One of the mechanisms contributing to T cell specificity of
GATA-3 expression is a silencing cis-regulatory element
where the zinc finger-homeodomain regulator ZEB (AREB6,
EF1) represses GATA-3 by competition with activating
bHLH factors (Gre´goire and Rome´o, 1999). ZEB is normally
expressed throughout early T cell development (M.K.A. and
E.V. Rothman, unpublished observations), and a partial
loss-of-function mutation causes a precipitous decrease in
cells entering the T cell developmental pathway, with
disproportionate losses of DN2 and DN3 cells (Higashi et
al., 1997). These effects are strongly reminiscent of the
effects of GATA-3 overexpression.
The relationship between the abnormal and normal func-
tions of PU.1 in thymocyte development is different. Our
previous work (Anderson et al., 2002) argues that PU.1
expression in thymocytes in vivo is linked with their
retention of non-T (myeloid, DC) developmental options.
Only a few of the genes implicated in T cell development
proper are known to be turned on in the early stages when
PU.1 levels are highest. One possible target, as noted
already, is IL-7R. PU.1 overexpression does not upregulate
IL-7R in our thymocyte or fetal liver precursor analyses,
but endogenous PU.1 (or the related factor Spi-B) levels
could be saturating for this target gene (Anderson et al.,
1999). It is particularly interesting that the T cell gene
preT does appear to be upregulated within 24 h of PU.1
transduction. CD25, the marker for DN2 and DN3 cells,
may also be positively regulated by PU.1 overexpression in
certain contexts (C.J.D. and E.V.R., unpublished results).
Normally, these genes are turned on in DN2 cells and
expressed in developmental stages even after PU.1 RNA
disappears. It is possible that during the normal course of T
cell development, preT upregulation is caused by the PU.1
family member Spi-B, since Spi-B is expressed at DN2 and
DN3, whereas PU.1 is downregulated at these stages
(Anderson et al., 1999). However, these effects show that
PU.1 activity is not directly antagonistic to all aspects of T
cell precursor gene expression. Substantial endogenous ex-
pression of Spi-B may obscure effects of added PU.1 on other
normal T lineage target genes.
A “First-State” Network Model for Early T Lineage
Specification
The effects on gene expression measured here are specifi-
cally those associated with inhibition of T cell develop-
ment, and they are likely to include both direct and indirect
transcription factor targets. However, we have raised the
possibility that the inhibitions result from a heterochrony
or exaggeration of a regulatory mechanism that has a
normal role to play in T lineage specification. To provide a
framework for testing this possibility, results from our
perturbation analyses can be combined with data from the
literature to begin to assemble connections among interact-
ing regulatory events that could ultimately drive T lineage
specification. A “first state” draft of such an assembly is
shown in Fig. 9 and ways that it might operate are discussed
in the companion paper (Rothenberg and Anderson, 2002).
While such a draft can only be a formalization of hypoth-
eses to drive future work, its architecture shows several
notable relationships which are consistent with normal
development and will likely remain as an armature for the
mature form of this regulatory network.
Figure 9 concentrates on the roles of PU.1 and GATA-3 in
the progression of T cell precursors to and through the
DN2/3 stages. Effects of transcription factor overexpression
on target genes that have been demonstrated in this study
and in our previous report (Anderson et al., 2002) are
indicated in Fig. 9 by bold lines, while relationships drawn
from the literature are shown by light lines. Besides genes
themselves, two kinds of “logic nodes” are shown in the
network: known direct interactions which are documented
biochemically (closed green squares); known cell type-
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FIG. 9. A “first-state” plot of regulatory relationships between transcriptional regulators and their targets in T lineage specification. The
diagram indicates the genes active in the interval from T lineage specification to -selection and selected genes that may be activated in
cells diverging from the T lineage path, with their relationships to perturbation by overexpression of PU.1 and/or GATA-3. Arrows indicate
positive regulatory effects and barred lines indicate inhibitory effects on the expression levels of the indicated genes. End states or
recognizable developmental states are highlighted with labels in yellow boxes. Stages at which Ras/PKC signaling pathways play a critical
role are indicated by lavender boxes; the signaling that initiates -selection is shown as a bold curved arrow. Other functions that are known
to contribute to -selection or myeloid differentiation are indicated as separate inputs. Data from this paper and our previous work
(Anderson et al., 2002) are indicated by bold arrows (upregulation) or bold barred lines (downregulation). Relationships indicated by other
data in the literature are indicated by thin arrows and barred lines. Three kinds of symbols are also used to represent conditional logic nodes
where the effect of a transcription factor is dependent on another known or unknown function: closed green squares (where biochemical
evidence for interaction is known), closed dark blue squares (cell type-specific survival function is required), and striped squares (effect is
context dependent; molecular basis of conditionality still uncharacterized). Thus, the known protein/protein interactions of Id2 and E2A
bHLH factors are indicated as a node with a closed green square symbol, while the cellular contexts that act as a switch for particular effects
of PU.1, e.g., for upregulation of preT or Id2 (see text), are indicated as regulatory nodes with striped square symbols. In the case of PU.1,
there is evidence for at least three dose-dependent or context-dependent effects on the same target genes, and these are indicated as broken
lines (see text). This study shows a modest positive effect of PU.1 on preT expression (bold dotted line), whereas in a DN3-like cell line,
it causes preT downregulation (Anderson et al., 2002); here, in thymocytes, there is little effect of PU.1 on Id2, but in some SCID.adh cells,
it turns on Id2 strongly; and finally, in this study, PU.1 overexpression causes a modest negative effect on IL-7R expression (light dashed
line), whereas other studies have found PU.1 at some level is essential for IL-7R expression (Scott et al., 1997; DeKoter et al., 2002). For
more extensive discussion of the predicted operation of this network, see the companion paper (Rothenberg and Anderson, 2002). Not
depicted here, but observed in several cases, PU.1 overexpression also reduces GATA-3 levels.
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specific survival functions (closed dark blue squares); and
other context dependencies for transcription factor effects,
i.e., conditional logic gates, at which key inputs remain
unknown (striped squares). The conditional relationships
include effects which may be indirect, as well as effects
which depend on the cellular context in which they are
assayed (for example, in fetal thymocytes as opposed to
SCID.adh or fetal liver cells; A.M.A., C.D., and M.K.A.,
unpublished results). Effects on target genes that change in
magnitude or even in direction depending on dose or on the
presence of coactivation are expected consequences of com-
binatorial transcription factor activity, as discussed exten-
sively in the companion paper (Rothenberg and Anderson,
2002). We can predict that lineage commitment is the
switch through which some of these conditional regulatory
linkages are cemented or broken.
The need for balanced activity of PU.1 and GATA-3 in T
cell development emerges from consideration of their ef-
fects on different functions that are essential for T cell
specification. This process depends both on a complex of
regulators (positively acting bHLH factors E2A and HEB,
c-Myb, HES-1, and PU.1 and GATA-3 themselves) and on a
minimum set of “effectors” (IL-7R for growth and sur-
vival, preT for pre-TCR assembly, and Rag-1 and Rag-2 for
TCR gene rearrangement). Figure 9 shows that the effector
genes in most cases are affected in parallel by overexpres-
sion of either PU.1 or GATA-3; for the most part, they are
downregulated to a greater or lesser extent (Rag-1, Rag-2,
IL-7R). These effects may or may not be direct. However,
the effects on certain regulatory intermediates in the cas-
cade show more dichotomous effects of PU.1 and GATA-3.
GATA-3 and PU.1 have opposing effects on HES-1 in fetal
thymocytes, with GATA-3 enhancing the expression of this
essential T lineage regulatory gene and PU.1 inhibiting it.
Furthermore, there appear to exist pathways through which
PU.1 can upregulate preT (this work) and, at a low dose,
IL-7R (Scott et al., 1997; DeKoter et al., 2002), while
GATA-3 seems to act more simply as an inhibitor of these
genes. Normally, genetic and expression data imply that all
these functions are needed together in the DN2 state
(Rothenberg and Anderson, 2002). The network thus shows
that T cell development can only proceed when the comple-
mentary positive effects of PU.1 and GATA-3 are compat-
ible with each stage-specific regulatory background, and
their levels of expression are kept low enough to avoid
driving the cells into forbidden regulatory states.
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